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Abstract. &Catenin is involved in the formation of 
adherens junctions of mammalian epithelia. It interacts 
with the cell adhesion molecule E-cadherin and also 
with the tumor suppressor gene product APC, and the 
Drosophila homologue of B-catenin, armadillo, medi- 
ates morphogenetic signals. We demonstrate here that 
E-cadherin and APC directly compete for binding to 
the internal, armadillo-like repeats of/5-catenin; the 
NH2-terminal domain of/3-catenin mediates the inter- 
action of the alternative E-cadherin and APC com- 
plexes to the cytoskeleton by binding to et-catenin. 
Plakoglobin (7-catenin), which is structurally related 
to/3-catenin, mediates identical interactions. We thus 
show that the APC tumor suppressor gene product 
forms strikingly similar associations as found in cell 
junctions and suggest hat/3-catenin and plakoglobin 
are central regulators of cell adhesion, cytoskeletal in- 
teraction, and tumor suppression. 
I 
T recently became vident hat the proper formation of 
intercellular junctions is critical for the maintenance 
of epithelial differentiation, and that destabilization of 
junctions allows invasiveness of epithelial cells and the 
progression of carcinomas (of. for review Tsukita et al., 
1993; Birchmeier et al., 1993). Interestingly, various struc- 
tural components of intercellular junctions have been found 
to be related to products of tumor suppressor genes. For in- 
stance, the adherens junction molecule E-cadberin sup- 
presses invasiveness of carcinoma cells, and the E-cadherin 
gene is mutated in 50% of the diffuse-type gastric carci- 
nomas (Behrens et al., 1989; Frixen et al., 1991; Vleminckx 
et al., 1991; Becker et al., 1994). The tumor suppressor gene 
product APC binds to B-catenin, which is cytoplasmically 
associated to E-cadherin (Rubinfeld et al., 1993; Suet al., 
1993; Nagafuchi and Takeichi, 1988; Ozawa et al., 1989). 
The tight junction-associated protein ZO-I is related to the 
dlg tumor suppressor gene product of Drosophila, and the 
neurofibromatosis-2 tumor suppressor gene product mer- 
lin/schwannomin is related to the ezrin/radixin/moesin fam- 
ily of junctional proteins (Woods and Bryant, 1991; Rouleau 
et al., 1993; Trofatter et al., 1993). Conversely, products of 
oncogenes have been demonstrated to destabilize intercellu- 
lar junctions, such as src, ms, fos, or met (Behrens et al., 
1993; Hamaguchi et al., 1993; Behrens et al., 1989; 
Shibamoto et al., 1994; Reichmann et al., 1992; Weidner et 
al., 1990). Src, the EGF receptor, and met phosphorylate 
B-catenin on tyrosine residues, which may modulate the 
adhesive properties of cells. 
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Adherens junctions of epithelial cells are specialized re- 
gions of the plasma membrane where transmembrane E-cad- 
herin molecules on opposing cells make contact with each 
other (Boiler et al., 1985; Tsukita et al., 1992; for a discus- 
sion of the related esmosomes see Garrod, 1993). The cyto- 
plasmic domain of E-cadherin forms complexes with ct-, B-, 
and 3,-catenin/plakoglobin, which are essential for the adhe- 
sive function (Nagafuchi and Takeichi, 1988; Ozawa et al., 
1989; Ozawa et al., 1990; Kintner, 1992). ot-Catenin shows 
sequence similarity to vinculin and interacts with the cyto- 
skeleton (Nagafuchi et al., 1991; Herrenknecht e al., 1991; 
Hirano et al., 1992). B-Catenin is the vertebrate homologue 
of the segment polarity gene armadillo f Drosophila and is 
related to plakoglobin (McCrea et al., 1991; Peifer et al., 
1992; Butz et al., 1992). 3,-Catenin is identical to plako- 
globin, which is also found in desmosomal junctions (Cowin 
et al., 1986; Franke et al., 1989; Knudsen and Wheelock, 
1992; Peifer et al., 1992; Hinck et al., 1994a,b; Niithke et 
al., 1994). Recent experimental evidence suggests that any 
significant change in expression or structure of one of these 
components leads to adherens junction disassembly and con- 
sequently, to non-adhesive and invasive cells. Molecular 
aberrations which result in such defects have been studied: 
an E-cadherin deletion mutant lacking its catenin binding re- 
gion was not functional in cell-cell adhesion when expressed 
in fibroblasts (Nagafuchi and Takeichi, 1988; Ozawa et al., 
1990). Cadherin mutants without the extracellular domain 
acted in a dominant-negative fashion, i.e., disturbed epithe- 
lial cell adhesion (Kintner, 1992). Apparently, these trun- 
cated molecules collect catenins, which are thus not avail- 
able to form proper complexes with intact E-cadherin. The 
adhesive properties of PC9 lung cancer ceils, which harbor 
a null mutation in the ct-catenin gene, could be restored by 
transfection with ct-catenin cDNA (Hirano et al., 1992). 
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Mutations of the E-cadherin gene have recently been discov- 
ered in 50% of diffuse-type gastric arcinomas, which lead 
to shortened mRNAs in which exons 8 or 9 are skipped 
(Becker et al., 1994). Mutations of the E-cadherin gene have 
also been identified in human ovarian carcinomas and in two 
non-adhesive c ll lines from gastric arcinomas (Risinger et 
al., 1994; Oda et al., 1994). 
Recently, the tumor suppressor gene product APC has 
been found to associate with the adherens junction proteins 
o~- and ~-catenin (Suet al., 1993; Rubinfeld et al., 1993). 
The APC gene codes for a cytoplasmic 300 kDa protein and 
is mutated in a high percentage ofcolon carcinomas, which 
represent 15 % of all cancers in the United States (Fearon and 
Vogelstein, 1990). Various genetic changes during colon 
cancer progression have been found, such as in the genes of 
APC, ras, p53, and DCC. Mutations of the tumor suppressor 
gene APC occur early during progression of the disease. 
Furthermore, an inherited isorder exists, Familial Adeno- 
matous Polyposis, also caused by APC mutations, which 
is characterized by an early onset of numerous polyps in 
the colon which progress to malignancy (Groden et al., 
1991; Kinzler et al., 1991). Little is known, however, about 
the functional role of APC in colonic epithelia, nor is it 
known why mutation of the APC gene product promotes co- 
lon cancer. 
It was previously unclear how the interaction between 
membrane-bound E-cadherin, the cytoskeleton, and the tu- 
mor suppressor gene product APC is organized on a molecu- 
lar level. There was indication that ~-catenin associates ear- 
lier than cz-catenin to E-cadherin during biogenesis of the 
adherens junction complex, and that B-catenin is also more 
strongly bound to E-cadherin (Ozawa et al., 1990; Hinck et 
al., 1994b). It has furthermore b en shown that catenin/APC 
immunoprecipitates do not contain E-cadherin (Suet al., 
1993), indicating that APC and E-cadherin might not be 
bound to/~-catenin atthe same time. We demonstrate h re 
that APC and E-cadherin compete for binding to/3-catenin, 
and that/~-catenin a d plakoglobin are direct but indepen- 
dent linkers between E-cadherin or APC and the cytoskel- 
eton-associated component ot-catenin. We also show that 
this link is mediated by different domains of ~-catenin, i.e., 
the armadillo-like repeats bind to E-cadherin and APC 
whereas the NH2-terminal domain is required for the inter- 
action to ot-catenin. 
Materials and Methods 
cDNA Constructs and Deletion Mutants 
The human/$-catenin cDNA was isolated from a eDNA library of placenta 
(HL1075B; Clontech, Palo Alto, CA) using the Xenopus eDNA (McCrea 
et al., 1991) as a probe. The 2,585-bp/3-catenin eDNA contains the com- 
plete coding region as well as 200- and 42-bp of 5'- and 3'-noneoding se- 
quence, respectively (ef. GenBank accession o. Z19054). The deduced 
amino acid sequence is highly similar to the Xenopus sequence (97% iden- 
tity), and identical to the mouse sequence xcept for one amino acid differ- 
ence at position 706 (cf. also McCrea et al., 1991; Butz et al., 1992). 13 
internal repeats of about 40 amino acids in length, as originally described 
for armadillo (Peifer and Wieschaus, 1990; Peifer et al., 1994), are flanked 
by unique NH2- and COOH-terminal sequences of 131 and 86 amino 
acids, respectively. Sequence comparisons were performed using the 
TFASTA, MOTIF, +TREE, MULTalign, and CLUSTAL program pack- 
ages of the HUSAR-system (European Molecular Biology Laboratory, 
Heidelberg, Germany). 
The human eDNA of/~-catenin was used for the generation of deletion 
mutants (Fig. 1 A). To detect B-catenin and the mutants by immunological 
methods, a tag epitope (EQKLISEEDL, derived from human c-myc; Evan 
et al., 1985) was added to either the NH2- or COOH-terminal side. Oligo- 
nucleotides coding for either the NH2-terminal or COOH-terminal tag plus 
respective start or stop eodons were first inserted into the pBluescript 
SKII + vector (Fig. 1 B). Deletions of ~-catenin containing appropriate re- 
strietion sites for cloning were then generated by PCR-mediated site- 
directed mutagenesis ( hown for the AN/C-term mutant in Fig. 1 C) and 
were inserted into the tag-containing vectors. The resulting eDNA con- 
structs were cloned into the pBAT expression vector (Nagafitehi and 
Takeichi, 1988). The eDNAs for mouse E-cadherin (Nagafuehi et al., 
1987), mouse a-catenin (Nagafuchi et al., 1991), and human plakoglobin 
(Franke et al., 1989) were also used in the pBAT vector. 
The fragment of APC encoding the/3-catenin binding site (Suet al., 
1993) was isolated from genomic DNA of human MCF7 cells by PCR using 
the primer pair 5'-CCATCCAGCAACAGAAAATCCA-3' and 5'-ACTTTT- 
GGAGGGAGATTTCGCT-3'. A NH2-terminal FLAG-epitope (MDYKD- 
DDDK; IBI, New Haven, CT) including atranslation i itiation site (Kozak, 
1986) and a stop codon were introduced at amino acid positions 957 and 
1211, respectively, by PCR-mediated site-directed mutagenesis using the 
primer pair 5 ' -GCGCCTCTAGACCGCCA~TACAAGGACGACG- 
ACGACAAG~CCGGGAGATCTTCAAATGATAGTTTAAATA-  
GTGTCAGT-3' and 5'-GCGCCGTCGACTATTAATGTTCGGTTTTACT- 
GC'ITII3T-3'. The resulting PCR product was introduced into the pBAT 
vector using XbaI/SalI sites. 
Cells and Immunological Methods 
The different eDNA constructs (15 #g each) were transiently transfectad 
into Neuro2A cells using the calcium phosphate method (Hartmann et al., 
1992). Neuro2A cells do not express E-cadherin, APC, or the catenins en- 
dogenously. After transfection with E-cadherin cDNA, some a- and B-cat- 
elfin protein expression was induced (ef. Nagafuehi et al., 1991), which 
represents a minor amount in comparison to the exogenously expressed pro- 
teins. Furthermore, ndogenous presence of catenins would not affect our 
results, since a- and/$-catenins do not form homodimers (el. below). Im- 
munodetection f the expressed proteins was carried out after two days of 
culture. Immtmofluorescence staining was performed as described (Bchrens 
et al., 1989) after fixation of the cells with methanol for 5 rain. For immtmo- 
precipitation, Neuro2A cells were labeled overnight with 20 #Ci/ml 
[35Slmethionine one day after tramfection, and cells were then extracted 
with 140 mM NaCI, 4.7 mM KC1, 0.7 mM MgSO4, 1.2 mM CaCI2, I0 
mM Hepes, pH 7.4, containing 1% Triton X-100, and 1 mM phenylmethyl 
sulfonylfluorid. After ultracentrifugetion at 100,000 g, the appropriate anti- 
bodies and protein A-Sepharose were added, and precipitates were washed 
with 100 m.M NaCI, 5 mM EDTA, 50 mM TrieJHCI, pH 8.0, containing 
1% Triton X-100, and 1 mg/ml ovalbumin (Behrens et al., 1989). Western- 
blot analysis was performed using the Western-Light protocol (Tropix Inc., 
Bedford, MA). The mouse mAb MyeI-9E10 (Evan et al., 1985) was used 
to detect the tag-epitope of the /3-catenin mutants, the mouse mAb 
anti-FLAG M2 (IBI) to detect he FLAG-epitope of the APC fragment. 
E-eadherin was detected with DECMA-1 antibody (Vestweber and Kemler, 
1985) and plakoglobin was with mouse mAb PG5.1 (Cowin et al., 1986). 
The anti-a-catenin antibody was produced in rabbits against a synthetic 
peptide (HVNPVQALSEFK)  corresponding to 12-amino acid residues 
near the COOH terminus. The anti-B-catenin antibody was raised in rabbits 
against a synthetic peptide (PGDSNQLAWFIYrDL)  corresponding to the 
last 14-arnino acid residues of the COOH terminus. 
Results 
Interaction between [3-Catenin, E-Cadherin, and APC 
We constructed deletion mutants of the human/3-catenin 
eDNA that encode proteins which lack either COOH- or 
NH2-terrninal domains or both, or which have truncations 
within the region of the 13 armadillo-like repeats (Fig. 1 A). 
In all constructs, a sequence ncoding an epitope of human 
c-myc was ligated to the 5'- or 3'-termini, which served as 
a tag to identify full size or mutant B-catenin immunologi- 
cally (Fig. 1, B and C). The location of the tag-epitope did 
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Figure 1. (A) Schematic 
representation f full-size and 
mutant /3-catenin and sum- 
mary of their ability to inter- 
act with E-cadherin or APC. 
On the left, the NH2- and 
COOH-terminal domains and 
the 13 internal armadillo-like 
repeats of/3-¢atenin areindi- 
cated by striped and shadowed 
boxes, respectively. The empty 
box between repeat 10 and 
11 indicates a stretch of un- 
repeated amino acids. The fol- 
lowing amino acid residues 
were deleted in the mutated 
proteins: AC-term, 696-781; 
AN-term, 1-131; AN/C-term, 
1-131 and 696-781; ACARll- 
13, 555-781; ANAR1-3, 1-258; 
ACARS-13, 424-781; ANAR1-7, 
1-422. On the right, a sum- 
mary of the binding studies 
between the 13-catenin mu- 
tants and E-cadherin or APC 
is presented. (B) Sequence 
of oligonucleotides encoding 
NH2- or COOH-terminal tag 
epitope (underlined) in the 
corresponding vectors are 
shown. A Kozak consensus 
sequence oftranslational initi- 
ation (Kozak, 1986), stop 
codons, and restriction sites 
used for cloning are indicated. 
(C) Generation of the f3-cate- 
nin deletions exemplified for 
the AN/C-term mutant. PCR 
products of the t3-catenin 
eDNA and 5' add-on primers 
containing start and stop co- 
dons as well as suitable restric- 
tion sites for the insertion into 
the two tag-containing vectors 
(B) are shown. 
not alter the interactions observed. The eDNA constructs 
were transiently transfected into Neuro2A cells (mouse 
neuroblastoma; cf. Hartmann et al., 1992), which neither 
express E-cadherin nor catenin proteins, as revealed by 
immunofluorescence and Western blot experiments; the ab- 
sence of APC expression was tested by Northern blotting 
(data not shown). When the E-cadherin and /3-catenin 
cDNAs were separately expressed, E-cadherin was located 
at the cell membrane while /3-catenin was diffusely dis- 
tributed throughout the cytoplasm, as revealed by im- 
munofluorescence staining (Fig. 2, a and b). When the two 
cDNAs were cotransfected, both proteins were membrane- 
associated, reflecting the direct interaction of/3-catenin with 
E-cadberin. Likewise, ~-catenin lacking both the NH2- and 
COOH-terminal domains was membrane-associated in the 
presence of E-cadherin (Fig. 2 c). However, ~-catenin lack- 
ing the NH2-terminal domain plus repeat units 1 to 7 did not 
associate with E-cadherin at the cell membrane (Fig. 2 d). 
Immunoprecipitations f/~-catenin from [35S]methionine- 
labeled Neuro2A cells with anti-tag antibodies corroborated 
these results: E-cadherin was associated with full-size/~-cat- 
enin as well as with mutants lacking either the COOH- or 
NH2-terminal domain or both (Fig. 3, A and B, lanes 2-5). 
However, deletion of repeat units 1 to 3 diminished binding 
to E-cadherin, deletion of repeats 11 to 13 abolished binding 
(Fig. 3 B, lanes 6 and 7); ~-catenin with larger truncations 
of repeat units did not bind (Fig. 3 B, lanes 8 and 9; cf. also 
Fig. 1 A for a summary). Interestingly, certain mutants of 
/~-catenin which alone did not bind (e.g., those lacking re- 
peats 1-7 and 11-13), were able to interact with E-cadherin 
when expressed in combination (Fig. 3 B, lanes 10 and 11 ). 
These mutant proteins directly interacted with each other 
even in the absence of E-cadherin (Fig. 3 C, lane I ). The 
interaction was mediated by overlapping repeat regions but 
not the terminal domains, since exact halves of/~-catenin did 
not interact (Fig. 3 C, lane 2). Interestingly, we could not de- 
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Figure 2. Immunofluorescence 
localization of recombinant 
E-cadherin and B-catenin in 
mouse neuroblastoma (Neu- 
ro2A) cells after cotransfec- 
tion with expression constructs 
for (a) E-cadherin, (b) B-cate- 
nin, (c) E-cadhedn plus B-cat- 
enin lacking the NH2- and 
COOH-terminal domains, and 
(d) E-cadherin plus/~-catenin 
lacking the NH2-terminal do- 
main and repeats 1 to7. Stain- 
ing was performed with (a) 
anti-E-cadherin antibody or 
(b-d) anti-tag antibody (MycI- 
9El0; Evan et al., 1985) to 
detect ~/-catenin. Bar, 20/zm. 
tect dimerization of full-size B-catenin (Fig. 3 D). The com- 
bined results show: (a) that interaction of B-catenin with 
E-cadherin is mediated by the armadillo-like repeats and not 
by the terminal domains; (b) that multiple rather than single 
repeat units are involved in the binding; and (c) that internal 
repeat units can interact with each other and thus cooperate 
in the binding to E-cadherin (cf. Fig. 7). 
We also identified the sequences of B-catenin that bind to 
APC and examined, how this binding is influenced by the 
formation of the E-cadherin//$-catenin complex. A fragment 
Figure 3. (A and B) Association of (tagged) wild-type and mutant 
B-catenin with E-cadherin, as revealed by immunoprecipitation of 
[35S]methionine-labeled cell extracts using anti-tag antibody (A, 
an autoradiograph is shown) followed byWestern blot analysis with 
anti-E-cadherin antibody (B). Neuro2A cells were cotransfected 
with expression constructs for E-cadherin and the various 13-catenin 
mutants as indicated above the figure. Control, E-cadherin expres- 
sion construct alone. The positions of the 15-catenin mutants in A 
are marked by arrowheads, the location of E-cadherin in B by an 
arrow. Western blotting (B) has been performed since contaminat- 
ing bands mask E-cadherin in A. Molecular weight markers are in- 
dicated. (C) Association of ~3-catenin mutants with each other in 
the absence of E-cadherin. Neuro2A cells were transfected with the 
~/-catenin mutant ANAR1-7 alone (lane 4) or in combination with 
the mutants ACAR1M3 (lane 1) or ACAR8-13 (lanes 2 and 3). 
[35S]Methionine-labeled cell extracts were immunoprecipitated 
with anti-B-catenin antiserum (lanes 1, 2, and 4) or anti-tag anti- 
body (lane 3, to reveal expression f both mutants). Note that the 
anti-B-catenin antiserum does not recognize mutants lacking the 
COOH-terminal domain. (D) Lack of homodimerization f full- 
size/%catenin. Neuro2A cells were transfected with B-catenin with- 
out a tag (lane 3), ~-catenin with a COOH-terminal tag (lane 4), 
or a combination ofboth (lanes 1 and 2). Immunoprecipitation was 
carried out using the anti-/3-catenin antiserum (lanes 1 and 3) or 
the anti-tag antibody (lanes 2 and 4), and precipitates were ana- 
lyzed by Western blotting with anti-B-catenin antiserum (top) or 
anti-tag antibody (bottom). Specific recognition f tagged and wild- 
type ~-catenin was possible, since the anti-/3-catenin antiserum 
does not detect i s epitope in the presence of a COOH-terminal tag. 
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Figure 4. (A) Association of the recombinant APC fragment with 
~-catenin mutants in cotransfected Neuro2A cells, as revealed by 
immunoprecipitation of APC using an anti-FLAG antibody fol- 
lowed by Western blot analysis of (tagged)/~-catenin with anti-tag 
antibody. The/3-catenin mutants used are indicated above. Control, 
APC expression construct alone. The lower band in lane 3 is a 
degradation product of the AN/C-term mutant which was observed 
in some xperiments. (B) Competition between E-cadherin and the 
APC fragment for binding to/3-catenin. Neuro2A cells were trans- 
fected with 15 #g expression constructs for each APC and/$-catenin 
plus increasing amounts of expression construct for E-cadherin 
(lanes 1 and 6, 0/~g; lanes 2 and 7, 1/~g; lanes 3 and 8, 2/xg; lanes 
4 and 9, 5 #g and lanes 5 and 10, 10 ftg). APC (lanes 1 to 5) and 
E-cadherin (lanes 6 to 10) were immunoprecipitated (IP) followed 
by Western blotting using anti-/3-catenin antiserum (top) or anti- 
FLAG antibody against APC (bottom). 
Figure 5. (A) Association of recombinant u-catenin with (tagged) 
/3-catenin mutants in cotransfected Neuro2A cells, as revealed by 
immunoprecipitation of [35S]methionine-labeled cell extracts us- 
ing anti-tag antibody (an autoradiograph is shown). The/3-catenin 
mutants used are indicated above and their positions are marked by 
arrowheads. Control, transfection of/3-catenin expression construct 
alone. The position of co-immunoprecipitated u-catenin ismarked 
on the left side. The anti-tag antibody also recognizes an unspecific 
120-kD protein which is unrelated to E-cadherin and is also present 
in untransfected cells. Lanes 5 and 6 were exposed three times longer 
than lanes I to 4. (B) Association of ot-catenin with t e E-cadherin/ 
catenin complex after expression of E-cadherin, ~-catenin, and 
(tagged)/3-catenin mutants lacking either the COOH-terminal do- 
main (lane 1) or the NH2-terminal domain (lane 2). The com- 
plexes were co-immunoprecipitated from [35S]methionine-labeled 
extracts using anti-tag antibody. (C) Association of APC to ct-cat- 
enin through linkage by ~catenin. Neuro2A cells were cotrans- 
fected with expression constructs for APC and u-catenin (lanes I 
and 2) or APC, ~catenin, and/3-catenin without the COOH-ter- 
minal domain (lane 3). Immunoprecipitation from [35S]methio- 
nine-labeled cell extracts was carried out sing anti-APC (FLAG) 
(lane 1 and 3) or anti-c~-catenin (lane 2) antibody. (D) Lack of 
homodimerization of ct-catenin. Neuro2A cells were cotransfected 
with expression constructs for a-catenin, wild type/~-catenin a d 
the tagged/3-catenin mutant lacking the COOH-terminal domain. 
Immunoprecipitation was performed f om [3~S]methionine-labeled 
cell extracts with anti-~-catenin a tiserum (lane 1 ) or anti-tag anti- 
body (lane 2). Note that the anti-~-catenin a tiserum is directed 
against an epitope in the COOH-terminal domain of ~-catenin. 
of the human APC gene encoding the/3-catenin-binding do-
main (amino acid residues 958-1210; Suet  al., 1993) was 
isolated, and an oligonucleotide encoding asynthetic epitope 
(FLAG) was ligated to the 5' end in order to detect he pro- 
tein immunologically. We found that the APC fragment also 
binds to the repeat units of/~-catenin and not the terminal do- 
mains (Fig. 4 A, lanes 2 and 3), and binding was again ot 
confined to an individual repeat but rather to a region cover- 
ing multiple repeat units (Fig. 4 A, lanes 3-7). In contrast 
to E-cadherin, however, the NH2-terminal part of the repeat 
region (repeat units 1 to 10) is sufficient for binding to APC 
(Fig. 4 A, lane 4; see also Figs. 1 A and 7, for a summary). 
Interestingly, the APC-binding site of/~-catenin could not be 
reconstituted by any combination of non-binding mutants, as 
it was found for the interaction f the/3-catenin mutants with 
E-cadherin (Fig. 4 A, lane 9; cf. Fig. 3, A and B; and Hiil- 
sken, J., unpublished results). 
The fact that both E-cadherin and APC bind to the repeat 
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units of/3-catenin raises the question whether the adhesion 
molecule and the tumor suppressor gene product compete 
for binding to B-catenin. Thus, Neuro2A cells were cotrans- 
fected with constant amounts of expression constructs for 
APC and fl-catenin as well as with increasing amounts of the 
E-cadherin expression construct. Gradual increase of E-cad- 
herin expression i deed induced aredistribution f/3-catenin 
from APC to E-cadherin (Fig. 4 B). 
fl-Catenin Links ~-Catenin to E-Cadherin and APC 
We have found that ~-catenin directly interacts with the 
cytoskeleton-associated component ct-catenin, as revealed 
by co-immunoprecipitation after transfection of Neuro2A 
cells with expression constructs for both components (Fig. 
5 A, lane 2). ot-Catenin was also co-immunoprecipitated 
with mutants of/3-catenin lacking repeat units 8 to 13 and/or 
the COOH-terminal domain (Fig. 5 A, lanes 3 and 5), but 
clearly not with mutants lacking the NH2-terminal domain 
(Fig. 5 A, lanes 4 and 6). When a combination of E-cadhe- 
rin, ot-catenin, and the (tagged) ~-catenin mutant lacking the 
COOH-terminal domain was expressed, anti-tag antibody 
immunoprecipitated a complex of all three components (Fig. 
5 B, lane 1); however, when the mutant of/3-catenin lack- 
ing the NH2-terminal domain was used, a complex without 
ot-catenin was seen (Fig. 5 B, lane 2). This indicates that 
ot-catenin does not directly interact with E-cadherin but in- 
directly through its interaction with/3-catenin (cf. also Fig. 
7). Accordingly, ot-catenin was only located at the cell mem- 
brane when coexpressed with E-cadherin and /3-catenin, 
as revealed by immunofluorescence experiments (data not 
shown). We also examined whether /3-catenin mediates a
similar linkage between c~-catenin and APC. In fact, APC is 
only indirectly linked to c~-catenin via/3-catenin (Fig. 5 C). 
It has been suggested that c~-catenin forms homodimers 
through its domain with sequence similarity to the vinculin 
homodimerization motif (Nagafuchi et al., 1991; Her- 
renknecht et al., 1991). We analyzed this by expressing a 
combination of ct-catenin, wild type /3-catenin (without a 
tag), and the tagged mutant of/3-catenin lacking the COOH- 
terminal domain. Since our anti-/3-catenin a tibody recog- 
nizes an epitope in the COOH-terminus, we could distin- 
guish the complexes c~-catenin/wild type /3-catenin and 
o~-catenin//~-catenin with COOH-terminal deletion (Fig. 5 
D). Apparently, ot-catenin does not homodimerize, since no 
quadruple complex (Bc~-c~Bmutant) was seen. 
Plakoglobin and B-Catenin Form Similar Complexes 
/3-Catenin and plakoglobin (3,-catenin) are structurally related 
consisting of central armadillo-like repeats flanked by NH:- 
and COOH-terminal domains (Franke et al., 1989; McCrea 
et al., 1991; Knudsen and Wheelock, 1992). We therefore 
investigated whether plakoglobin may similarly form a com- 
plex with E-cadherin or APC. When a quadruple combina- 
tion of E-cadherin, ~catenin, ~catenin, and plakoglobin 
was expressed, anti-plakoglobin antibody immunoprecipi- 
tated a complex including E-cadherin and ~-catenin, but not 
B-catenin (Fig. 6 A, lane 1 ); conversely, anti-/3-catenin a ti- 
body identified a complex containing E-cadherin and ot-cate- 
nin, but not plakoglobin (Fig. 6 A, lane 3). Plakoglobin also 
binds to o~-catenin the absence of E-cadherin (Fig. 6 B, 
lane 2), but here was no direct association with/3-catenin 
(Fig. 6 B, lane 3). Furthermore, plakoglobin can also substi- 
tute for B-catenin in the APC complex (Fig. 6 C). These re- 
suits suggest that: (a) the structurally related molecules plako- 
globin (3,-catenin) and B-catenin mediate binding between 
E-cadherin or APC and o~-catenin i two mutually exclusive 
complexes; and that (b) similar molecular interactions occur 
in plakoglobin- or B-catenin-containing complexes. 
Discussion 
We have here expressed the cDNAs of E-cadherin, APC, and 
three catenins (including various deletion mutants of/~-cate- 
nin) in the suitable xpression system of Neuro2A cells. We 
could reconstruct the molecular interactions under condi- 
tions which closely resemble the in vivo situation. With anti- 
bodies against all the expressed proteins (the/3-catenin mu- 
tants and APC carried an added epitope), we were able to 
monitor the respective associations between these compo- 
nents by specific o-immunoprecipitation. Our data allow us 
to model the multiple interactions of/~-catenin which may 
occur within adherens junctions and the APC complex (Fig. 
7): B-catenin or plakoglobin directly interact with either the 
cell adhesion molecule E-cadherin or the tumor suppressor 
Figure 6. (A) ~-Catenin and 
plakoglobin form distinct 
complexes with E-cadherin. 
Immunoprecipitations of psS]- 
methionine-labeled Neuro2A 
cells transfected with a combi- 
nation of expression constructs 
for E-cadherin, ot-catenin, 
B-catenin, and plakoglobin 
were carried out with anti- 
bodies against plakoglobin 
(lane 1 ), E-cadherin (lane 2),
or/3-catenin (lane 3). The lo- 
cation of inununoprecipitated proteins is marked on the left. (B) Plakoglobin directly associates with c~-catenin. Immunoprecipitations 
with anti-plakoglobin antibody were performed fr m [3sS]methionine-labeled c lls transfected with expression constructs for c~-catenin 
and/~-catenin (control, lane 1 ), c~-catenin a d plakoglobin (lane 2), or ~/-catenin a d plakoglobin (lane 3). (C) Association of APC with 
plakoglobin and linkage of c~-catenin to APC through plakoglobin. Neuro2A cells were cotransfected with expression constructs for APC 
and plakoglobin (lane 1 ), or APC, ~catenin, and plakoglobin (lane 2). Immunoprecipitation from [35S]methionine-labeled c ll extracts 
was carried out sing anti-APC (anti-FLAG) antibody. 
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Figure 7. Schematic representation of the E-cadherin and APe 
complexes with/~-catenin or plakoglobin. B-Catenin/plakoglobin 
interact with the cytoplasmic region of the cell adhesion molecule 
E-cadherin via their internal a madillo-like r peats (drawn as links 
of a chain), tx-Catenin, which mediates the connection to the 
cytoskeleton, binds to the NH2-terminal domain of B-catenin. No 
function has yet been assigned to th  COOH-terminal domain of 
/3-catenin. ~Catenin/plakoglobin also interact with APC through 
the armadillo-like r peats. The three/~-catenin-binding repeats of 
APe (Suet al., 1993) are shown. We also indicate that the repeat 
units of B-catenin may form an i tramoleculax oop and that the re- 
peats located more NH2- or COOH-terminally interact preferen- 
tially with APC or E-cadherin, respectively. 
gene product APC, and APC and E-cadherin actually com- 
pete for binding to the region of the internal, armadillo-like 
repeats of B-catenin. Furthermore, B-Catenin and plako- 
globin are direct linkers of both E-cadherin and APC to the 
cytoskeleton-associated protein ot-catenin. This link re- 
quires a distinct region of B-catenin, the NH2-terminal do- 
main. ~-Catenin and plakoglobin are thus centrally located 
in both the cell adhesion and the APC complexes, and it is 
also evident hat the overall structural arrangement of the 
E-cadherin/catenin and the APC/catenin complexes i simi- 
lar (Fig. 7). These findings indicate that/~-catenin/plako- 
globin represent important links in the communication be- 
tween cell adhesion, cytoskeletal interaction, and tumor 
progression. 
There exist distinct differences, however, between the 
E-cadherin/catenin a d APC/catenin complexes. No simi- 
larity in the primary structure between the catenin-binding 
region of E-cadherin or APC can be recognized (Suet al., 
1993). Furthermore, we observed ifferences in the binding 
of B-catenin mutants to the cell adhesion molecule and the 
tumor suppressor gene product, i.e., deletion of NH2- or 
COOH-terminal rmadillo repeat units affected binding dif- 
ferently. Apparently, there exist two subregions within the 
repeat sequence of ~-catenin, to which E-cadherin and APC 
bind preferentially. Nevertheless, E-cadherin clearly com- 
petes with APC for the binding to B-catenin. Although we 
have not thoroughly studied binding affinities, it seems that 
E-cadherin binds more strongly, i.e., at comparable expres- 
sion levels of APC and E-cadherin, B-catenin is linked pri- 
marily to E-cadherin. Our finding that E-cadherin and APC 
bind to catenins in separate complexes i in line with previ- 
ous observations, i.e., the two components could not be co- 
immunoprecipitated (Suet al., 1993). 
APC and E-cadherin are both involved in the suppression 
of neoplastic transformation a d invasiveness (Fearon and 
Vogelstein, 1990; Birchmeier et al., 1993; Behrens et al., 
1989; Frixen et al., 1991; Vleminckx et al., 1991); we might 
therefore speculate that both components cooperate in this 
function via the competitive interaction with /~-catenin. 
B-Catenin has been suggested tomodulate E-cadherin-medi- 
ated cell adhesion during processes which require reduced 
cell adhesion, such as cytokinesis and cell movement, and 
tyrosine phosphorylation f/~-catenin interferes with E-cad- 
herin function (Behrens et al., 1993; Hamaguchi et al., 
1993; Shibamoto et al., 1994). APC could thus sequester 
negative regulatory variants of 15-catenin and prevent heir 
interaction with E-cadherin. Alternatively, APC might di- 
rectly interfere with E-cadherin-mediated cell adhesion, 
e.g., promote shedding of epithelial ceils into the colonic lu- 
men. As a correlate, APC expression has been found to in- 
crease from the base of the colonic crypts to the luminal sur- 
face (Smith et al., 1993). Absence or mutation of APC might 
thus promote progression of colon carcinomas by retention 
of proliferating cells, which then could collect further muta- 
tions known to contribute to the progression f colon cancer 
(Fearon and Vogelstein, 1990). It is generally accepted that 
E-cadherin regulates cytoskeletal organization through its 
interaction with the catenins (Ozawa et al., 1990; McNeill 
et al., 1990). The structural similarity of the E-cadherin and 
APC complexes could also indicate that APC exerts its tumor 
suppressor function through modulation of the cytoskeleton. 
APC has been detected inthe 100,000 g insoluble membrane 
fraction and was recently found to be associated with 
microtubules (Smith et al., 1994; Munemitsu et al., 1994). 
We have further demonstrated thatplakoglobin can inter- 
act with either the cell adhesion molecule E-cadherin or the 
tumor suppressor gene product APC in the same manner as 
15-catenin. B-Catenin and plakoglobin might thus be func- 
tionally redundant; his question can now be examined in 
systems where the gene for one or the other is deleted. Alter- 
natively, ~-catenin and plakoglobin might have functionally 
different roles and may be the subject of separate r gulation. 
It is known that both proteins differ in their association with 
cell junctions in vivo, i.e., B-catenin is largely associated 
with adherens junctions whereas plakoglobin is also part of 
desmosomes (Cowin et al., 1986). That 15-catenin and 
plakoglobin form mutually exclusive complexes with E-cad- 
herin has recently also been suggested by Hinck et al. 
(1994a). 
Recent evidence suggests hat/~-catenin, besides function- 
ing in adhesion complex formation and in the interaction 
with APC, is also involved in signal transduction: its homo- 
logue armadillo is part of a signal cascade from wingless (the 
vertebrate homologue is wnt-1) to engrailed in determining 
segment polarity in Drosophila (Bejsovec and Wieschaus, 
1993; van Leeuwen et al., 1994). Interestingly, overexpres- 
sion of wnt-1 in Xenopus embryos results in a duplication of 
the embryonic axis, and the same phenotype occurs after 
microinjection of anti-~-catenin antibody into early em- 
bryos (Sokol et al., 1991; McCrea et al., 1993), which sug- 
gests similar signalling events also during vertebrate devel- 
opment. In mammalian cells, it has been shown that wnt-1 
expression results in a strong accumulation f~-catenin and 
plakoglobin at the cell membrane and in the strengthening 
of Ca2+-dependent adhesion (Bradley et al., 1993; Hinck et 
al., 1994a). It remains to be determined whether t se sig- 
nalling processes make use of/~-catenin in a membrane- 
associated complex or whether independent interactions 
occur .  
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